/cloudfront-us-east-2.images.arcpublishing.com/reuters/ELYBYTG4QZMUJPXRYDKAVNSTAI.jpg "New branded drugs helping Teva Pharm move closer to growth | Reuters")
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Pharmaceutical Stock Could Double | Barron's
Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Teva to cut 14,000 jobs | Business | Chemistry World
Sex, drugs, and sharing trade secrets
FDA Approves Generic Version Of Teva's Blockbuster Drug - Drug Discovery and Development
Generics distributor Anda, Inc. has a new owner: Teva Pharma
Teva bullish ahead of 2-step biosimilar attack on AbbVie's blockbuster Humira
Teva Pharmaceutical Industries Ltd. | BioWorld
Declining sales of blockbuster drug drag Teva revenue lower - MarketWatch
Silver Spring-based United Therapeutics settles patent dispute over Remodulin generic with Teva Pharmaceuticals - Washington Business Journal
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva files potential blockbuster migraine drug for FDA approval
Teva agrees to buy Allergan's generics distribution unit
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
Teva's Blockbuster Drug Takes Another Generic Blow | Ctech
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
Report: Teva Suffers Migraine Over Express Scripts Drug Exclusion - Pharmaceutical Processing World
A determined FDA takes down Teva's blockbuster | Evaluate
